Legal Representation
Attorney
Craig Kuchii
USPTO Deadlines
Next Deadline
57 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
September 07, 2025
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 7, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Jul 7, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 3, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 22, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 22, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 2, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 16, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 23, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
Additional Information
Design Mark
The mark consists of the stylized word LEQSELVI in gradiant blue.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Classification
International Classes
005